Triangle Capital Corp:企業のM&A・事業提携・投資動向

◆英語タイトル:Triangle Capital Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1357
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:96
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Triangle Capital Corp – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Triangle Capital Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Triangle Capital Corp since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Triangle Capital Corp’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Triangle Capital Corp. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Triangle Capital Corp’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Triangle Capital Corp and its subsidiaries since 2007.
- Information about key financial and legal advisors for Triangle Capital Corp’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Triangle Capital Corp’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 17
Corporate Venturing – Overview 17
Corporate Venturing – Deal reports 18
CAPITAL RAISING 51
Capital Raising – Overview 51
Capital Raising – Deal reports 52
DIVESTMENTS 80
Divestments – Overview 80
Divestments – Deal reports 81
PRIVATE EQUITY & OWNERSHIP 82
Private Equity and Ownership – Overview 82
Private Equity and Ownership – Deal reports 83
APPENDIX 86
Contact Us 86
About MarketLine Financial Deals Database 86
Deal Definition and Methodology 88
About MarketLine 95

List of Tables
Table 1: Triangle Capital Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Triangle Capital Corporation M&A activity by geography (2014-YTD2018)
Table 3: Triangle Capital Corporation corporate venturing volume and value trend (2014-YTD2018)
Table 4: Triangle Capital Corporation corporate venturing by geography (2014-YTD2018)
Table 5: Triangle Capital Corporation capital raising volume and value trend (2014-YTD2018)
Table 6: Triangle Capital Corporation capital raising by deal type (2014-YTD2018)
Table 7: Triangle Capital Corporation divestments volume and value trend (2014-YTD2018)
Table 8: Triangle Capital Corporation private equity and ownership volume and value trend (2014-YTD2018)
Table 9: Triangle Capital Corporation private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: Triangle Capital Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Triangle Capital Corporation M&A activity by geography (2014-YTD2018)
Figure 3: Triangle Capital Corporation corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Triangle Capital Corporation corporate venturing by geography (2014-YTD2018)
Figure 5: Triangle Capital Corporation capital raising volume and value trend (2014-YTD2018)
Figure 6: Triangle Capital Corporation capital raising by deal type (2014-YTD2018)
Figure 7: Triangle Capital Corporation divestments volume and value trend (2014-YTD2018)
Figure 8: Triangle Capital Corporation private equity and ownership volume and value trend (2014-YTD2018)
Figure 9: Triangle Capital Corporation private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[Triangle Capital Corp:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Southern Copper Corporation:企業の戦略・SWOT・財務情報
    Southern Copper Corporation - Strategy, SWOT and Corporate Finance Report Summary Southern Copper Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cognition Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cognition Therapeutics Inc (CogRx) is a drug discovery and development company that discovers and develops small molecule therapeutics. The company uses its proprietary biology and chemistry platforms for the development of novel drug targets and disease modifying therapies for the treatment …
  • Chubb European Group SE:企業の戦略的SWOT分析
    Chubb European Group SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Viridian Energy Supply Ltd.:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Selex Gruppo Commerciale S.p.A.:企業の戦略・SWOT・財務情報
    Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Selex Gruppo Commerciale S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務情報
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • GeeCee Ventures Ltd (GEECEE):企業の財務・戦略的SWOT分析
    GeeCee Ventures Ltd (GEECEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • 3-V Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary 3-V Biosciences Inc (3-V Biosciences) is a clinical-stage pharmaceutical company that develops novel therapeutics in metabolic diseases. The company offers TVB-2640, a fatty acid synthase inhibitor used for the treatment of solid tumors, including non-small cell lung cancer (NSCLC), breast c …
  • Artios Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Artios Pharma Ltd (Artios Pharma) is an independent company that focuses on the development of DNA Damage Response (DDR) therapies to treat cancer. The company has in-licensed its lead DDR programme, DNA polymerase theta (PolO) from Cancer Research Technology (CRT), which target proteins tha …
  • Dow Jones & Co Inc:企業の戦略的SWOT分析
    Dow Jones & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • OncoSec Medical Inc (ONCS):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Carnegie Private Bank:企業の戦略・SWOT・財務情報
    Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report Summary Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aero-Tech Engineering, Inc.:企業の戦略・SWOT・財務情報
    Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero-Tech Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Anthem, Inc.:企業のM&A・事業提携・投資動向
    Anthem, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anthem, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • CKE Restaurants Holdings Inc.:企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Valensa International LLC:企業の戦略・SWOT・財務情報
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • DermTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary DermTech Inc (DermTech) is a dermatology company that develops non-invasive gene expression tests to facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The company’s products include adhesive skin sample collection kit, that allows co …
  • Energy Future Holdings Corp.-エネルギー分野:企業M&A・提携分析
    Summary Energy Future Holdings Corp. (EFH Corp) is an electric utility company. It manages a portfolio of competitive and regulated energy companies serving the Texas electricity market. The company’s competitive businesses consist of Luminant, which is involved in power generation and related minin …
  • HOB Biotech Group Suzhou Co Ltd:医療機器:M&Aディール及び事業提携情報
    Summary HOB Biotech Group Suzhou Co Ltd (HOB Biotech) is a manufacturer of allergy and autoimmune in vitro diagnostics. It owns and operates bioclia, bioline, and biolisa. The company’s bioclia is engaged in cutting-edge nanoparticle and chemiluminescent technology, and chemiluminescent immuno assay …
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆